Silence Therapeutics reported $12.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AstraZeneca USD 11.55B 674M Sep/2026
Autolus Therapeutics Ltd USD 85.73M 11.02M Mar/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 9.88B 325M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Silence Therapeutics USD 12.5M 13.91M Dec/2025